Research analysts at StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a research note issued to investors on Thursday. The firm set a “sell” rating on the stock.
Ampio Pharmaceuticals Stock Performance
Shares of Ampio Pharmaceuticals stock opened at $0.00 on Thursday. The stock has a 50 day moving average of $0.01 and a 200 day moving average of $0.02. The firm has a market capitalization of $2,951.00, a price-to-earnings ratio of 0.00 and a beta of 3.67. Ampio Pharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week high of $2.91.
Ampio Pharmaceuticals Company Profile
Further Reading
- Five stocks we like better than Ampio Pharmaceuticals
- What is the Euro STOXX 50 Index?
- Work and Play: Investing in the Rise of Bleisure Travel
- Do ETFs Pay Dividends? What You Need to Know
- Top Dividend Stocks to Buy Now as Bond Yields Could Lower
- How to Invest in the Best Canadian Stocks
- SAP: AI Tailwinds Accelerating Enterprise Cloud Business
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
